药明康德中期报告2024

WuXi AppTec Co., Ltd.* 2359 2024 目 錄 2 5 6 35 71 72 74 76 78 80 126 118 •88135 333 50147 288 33 3485 47917 81–38 201 1283 8 •••1151509 28824 A 188 H 1617 A603259H02359 www.wuxiapptec.com.cn 財務摘要 1. A. 17,240.98.6%4,239.820.2% CRDMOCTDMO 20246,00050020246431.033.2% —2065.911.9% —107.11.2%22.25.3%34.02.8%9.117.4% (1)WuXi Chemistry 122.12.1% —RResearch457%CRDMORD&M —DMDevelopment and ManufacturingD&M73.950%2.7%CDMO202464420246D&M3,3196774III353II2,825IIII1420245 —TIDESTIDES20.857.2%20246TIDES147%TIDES D&M15125%28839%2024132,000L (2)WuXi Testing 30.2 —21.25.4%6.3%(OECD)GLP(PMDA)mRNA —CROSMO8.95.8%SMO20.4%CRO14SMO31SMO (3)WuXi Biology 11.7 —8.1%29.0%26020211,200 —202430% —20% (4)WuXi ATU CTDMO5.7 —(1)(2)(3) —CTDMO202466425III28II49I1TILCAR-TLVVBLA(PPQ)PPQ2024FDACAR-TBLA20242025FDA 2024383–4052.7–8.6% 20242024 6,700.9202311.3%38.9%1.2 20236301,061.22024630208.4(1)551.9(2)191.0(3)124.9 202363076.52024630115.8(1)WuXi XDCCayman Inc.126.6(2)WuXi Healthcare VenturesII, L.P.64.1 20236305,356.920246304,280.820.1%28.4%24.8% 20246304,738.8202363011.3%202415.048.3%2023 20246301,745.9202363033.5% 20246303,463.1202363032.5%A 202463019,302.62023123118,151.935.1%30.1%13.1%21.7% (1) 20246305,811.62,919.32,892.32,189.53,622.12,189.5300.03,622.1 (2) 20246301.6202312311.60.4% (3) 2024630 (4) 202463025.9%2023123124.6% B. EBITDAEBITDAEBITDAEBITDA(i)(ii)(iii) EBITDAEBITDAEBITDA D. 2024630 (1)(2)(3)(4) 12.2 270.1 2024630 Genesis Medtech Group LimitedGenesis Genesis2024630Genesis1,642.52.2% Genesis2024630Genesis1,5172,00050% iKang Healthcare GroupiKang iKang2024630iKang486.90.7% iKang201912024630iKang5915410iKang200800 2024630289.80.4% 2011CRO2024630185.60.2% 2024630170.30.2% (RDC)FIC/BICPET-CTBR-02INDFDACDERDC(IIT)RDC 20246305% E. (1) (2) WuXi TIDES(TFF)CMCPROTAC (3) 20 2024132,000L20245CRDMOD&M2025D&M50% (4) 20 4,0002512203410 (5) F. (1)2019 AA 2024312019A12019A83,629AA0.0033%0.0028%A202437202431 20243182019A122019A101,376AA0.0040%0.0034%A20243222024318 (2)2019 20192019202362720245253111,690,93338.622023619 202463030720191,659,424AAA(T)(T+1)A(T+2)2019202452531,5092024712024729 (3)2023 20246122023202320232024625109.8974202451020245272024612 (4)2022H2022 20222022292,040382022H0.0754%0.0100%20241112024624 (5)2023H 202310302023HH2023H15,467,500H 20234242023103020234272023531 (6)2024H 202461220232024H202420242024H 202442920245102024612 2. A. B. (1)(2)(3)(4)(5) C. 2024 (1) (2) (3) 2024 (4) PROTAC (5) (1)(2)(3)(4) (6) (7)(ESG) 2024(UNGC)ESGESGESG D. (1) (2) (3) CRO/CDMO (4) (5) 202436S.35582024515H.R.8333H.R.7085H.R.8333 H.R.833320252025202520252024710 ————— (6) (7) (8) (9) (10) A AA2,130.32024630A269.2 AA20244262023 A A6,461.22024630A71.1 A202033120244262023 H HHH7,032.62024630H166.0 H20244262023 H 202085H6,558.62024630H639.4 H2024630 (1)(2)2023630(3)2024318H20231231202512312024318(4) 29420199172,079.5 法定披露 H 2024152023HH(i)2024(ii) A2024A(iii) H2024H202312132023H15,467,500H 2024115H202411820241182024118 A 202421AA 20242520,275,407A0.69%20242520,275,407A20243202024222024252024320 A 202438AA 2024522A21,593,7800.74%21,593,780A202452420243820245232024524 20244262023 2023123113.51B(1) (1)20244WuXi XDC Hong Kong Limited(2)20246(3)20243WuXi Biologics Holdings Limited(4)2024220244(5)20246 13.51B(1) 2018A201920246302018A2019 2023H20246302023H20232023H2023 1. 2024630AAHH 2.2019A 20199202019A21,055,530A2019A2,467201911252,008A32.4413,400,273A124,443A5,039,904460A64.8820192019112520206101840.59427,000A29,1311A81.1720192020610 2020515104103.372019AA 2021513102103.632019AA 20246302019A2019A 20192019201954201920191830422019A2019 20192019542019AA20192019 2019A 201964.88 (1)2019A1A164.88 (2)2019A60A606060.56 201920192019202064201964.8846.34202020202020202168201946.3438.62 201981.17A (1)20191A1 (2)20192060120A20601202060120 A107.1438.62 Black-Scholes2019A 2019A A 89.9064.8843.44%–45.85%1.5–4.52.81%–2.91%0.95% 2019AA (1)2019202452531,5092024712024729 3. 2015(i)2015(ii)(iii)2016 2017913102020175201841010.03.52015201616,200,0006,708,8431,525,140201520168.001.798.00 201520161020%20%20%40% 4. 2016516201771220162017201620171,350,000123,000201620178.008.00 1020%20%20%40% 2024630 5.2020H 20207212020H20202020700H202020202020202020202020202012202041,923,641.0020202023Wendy J. Hu20208312020H20202020202072120208312020812 2020H202020202020HH2020H20202020H 202020202020 20202020 20246302020H1,9432020820201,93520202020 2020H202020201216202172202111102022121 1.Wendy J. Hu 2.20202020202020202020202020202020 3.2021682020202167202020202020 4.20202020 5.202020202020 6. 2020H2020 2020202020202020 20202020(i)202020202020(ii)2020 7.202043.13 8. 2020H20202020 202020202020H202020202020B100%B02020202020202020 20202020812— II.H—— 9.2020H2020122202099.502021612020174.80202111102020157.0020221212020121.00 6.2021H 2021822021H2021202120H20212021202